Low-Grade Glioma, NOS
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | BRAF p.V600E | Low-Grade Glioma, NOS | Dabrafenib, Trametinib | |
| Sensitivity (+) | BRAF p.V600E | Low-Grade Glioma, NOS | Dabrafenib, Trametinib | |
| Sensitivity (+) | BRAF rearrangements | Low-Grade Glioma, NOS | Tovorafenib | |
| Sensitivity (+) | v::BRAF | Low-Grade Glioma, NOS | Tovorafenib | |
| Sensitivity (+) | BRAF p.V600E | Low-Grade Glioma, NOS | Tovorafenib | |
| Sensitivity (+) | BRAF p.V600K | Low-Grade Glioma, NOS | Tovorafenib | |
| Sensitivity (+) | BRAF p.V600E | Low-Grade Glioma, NOS | Dabrafenib, Trametinib | |
| Sensitivity (+) | BRAF p.V600E | Low-Grade Glioma, NOS | Dabrafenib, Trametinib |